November 13, 2025
Dear Reader,
In this issue, we bring you several key updates in vaccinology and public health.
Recent research continues to advance our understanding of tick-borne encephalitis (TBE). After LRP8 was identified as a receptor for the TBE virus (Snapshot Week 46/2025), a study by Li et al. has now confirmed its role across all five TBE subtypes.
We also feature a new “real-world” randomized study showing that influenza vaccination can reduce the risk of myocardial infarction. Although this link has been discussed for decades, this study offers strong confirmation of earlier evidence.
Findings like these deserve greater visibility, especially in vaccine package inserts. While adverse events are routinely listed, protective benefits such as cardiovascular risk reduction often are not. You can read my full perspective and call to action in this issue.
As we look back on World Vaccination Day (10 November) and World Immunization Week (24–30 April), it is worth remembering their shared mission: improving vaccine awareness and literacy. This is especially relevant for those working in health-literacy initiatives.
In this week’s Vaccine Industry News, we highlight updates from Dynavax, Novavax, the Serum Institute of India, and a new partnership in Saudi Arabia. Our featured infographic focuses on licensing and outlines what physicians should know when navigating vaccine approval and distribution.
Also recommended this week:
- New safety data on the VLP chikungunya vaccine
- Insights into avian influenza virus replication in human respiratory organoids
- Findings on immune responses to vaccination against Onchocerca volvulus
- The WHO’s new R&D Roadmap for Oropouche virus
- The weekly global influenza and ARI update
Editor-in-Chief, Global Health Press
|
Your go-to source for concise
updates on the latest developments in the world of vaccines.
This week's VacciNEWS viewpoint: |
|
Infographic of the weekVacciTUTOR is our CME-accredited online course dedicated to vaccines and vaccination. Developed by leading international researchers, the course offers over 60 comprehensive chapters covering fundamental topics such as microbiology and immunology, as well as detailed insights into vaccine-preventable diseases and their corresponding vaccines. Concise bullet-point summaries are available free of charge to support quick reference and learning. Feel free to download today’s vaccine licensure infographic » |
|
The TBE SnapshotSnapshot (Week 46, 2025) Researchers have identified LRP8 as a key receptor for tick-borne encephalitis (TBE) viruses. LRP8 helps the virus enter human and neuronal cells, and this applies across all five known TBE subtypes. Blocking LRP8 can reduce infection and protect against disease in experimental models. This discovery improves our understanding of TBE infection and opens doors for new treatments and vaccine strategies. |
|
Promoting trust through vaccination awarenessThis week, Health Literacy in Asia features a spotlight on World Immunization Week, reminding us that “Immunization for All is Humanly Possible”. We highlight key messages from the World Health Organization about the vital role of vaccines across the life-course — and underscore how strengthening vaccine awareness and trust is essential for public health across Asia. |
Be Part of the Global Health Press Community - id-ea.org
Join our GHP community and access exclusive, subscriber-only articles, expert reviews, and in-depth features. By becoming a subscriber, you’ll stay ahead of the news with the latest vaccines and vaccination updates. Enjoy content designed specifically for our engaged audience.
We’re also excited to welcome contributors who share our passion for advancing the field of vaccines and vaccination, public health and education. Whether it’s submitting an article, serving as a Country Editor, contributing research, or hosting a webinar, there are many ways to get involved.
Become part of the conversation and strengthen global health together with us.
Subscribe and join today!
Contact us at info@globalhealthpress.org to learn more.
| Let’s get the word out! : | |
|
|
| Like what you read? Forward this email to your friends or colleagues. | |
| Invite your friends |
Your contact details are never shared with third parties. If you no longer wish to receive updates from us, you can unsubscribe here.
© Copyright 2025 Global Health Press Pte Ltd. Reg. No. 200921795N